Synnöve Lindemalm

Publications
CV
Public outreach and news

Articles

Article: JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023;29(4):818-825

Improved home management of oral pediatric anticancer drugs as a result of an intervention comprising practical training, written instructions and movie clips: A pilot study.

Akkawi El Edelbi R; Eksborg S; Ekman J; Lindemalm S
Article: JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2023;29(1):94-100

Parents' experiences of handling oral anticancer drugs at home: 'It all falls on me …'.

Akkawi El Edelbi R; Eksborg S; Kreicbergs U; Lövgren M; Wallén K; Ekman J; Lindemalm S
Article: PHARMACEUTICALS. 2022;16(1):8

Manipulated Oral and Rectal Drugs in a Paediatric Swedish University Hospital, a Registry-Based Study Comparing Two Study-Years, Ten Years Apart.

Andersson ÅC; Eksborg S; Förberg U; Nydert P; Lindemalm S
Article: INTERNATIONAL JOURNAL OF PEDIATRICS AND ADOLESCENT MEDICINE. 2021;8(4):221-228

Estimation of body surface area in neonates, infants, and children using body weight alone.

Akkawi El Edelbi R; Lindemalm S; Nydert P; Eksborg S
Article: ACTA PAEDIATRICA. 2020;109(12):2810-2819

Cross-sectional study identifying high-alert substances in medication error reporting among Swedish paediatric inpatients.

Nydert P; Kumlien A; Norman M; Lindemalm S
Article: DRUG, HEALTHCARE AND PATIENT SAFETY. 2020;12:31-40

Drug Use and Type of Adverse Drug Events-Identified by a Trigger Tool in Different Units in a Swedish Pediatric Hospital.

Nydert P; Unbeck M; Pukk Härenstam K; Norman M; Lindemalm S
Article: ONLINE JOURNAL OF PUBLIC HEALTH INFORMATICS. 2017;9(3):e200

Pediatricians' Understanding and Experiences of an Electronic Clinical-Decision-Support-System.

Nydert P; Vég A; Bastholm-Rahmner P; Lindemalm S
Article: STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS. 2017;234:256-261

Evaluation of Electronic Prescribing Decision Support System at a Tertiary Care Pediatric Hospital: The User Acceptance Perspective.

Omar A; Ellenius J; Lindemalm S
Article: LAKARTIDNINGEN. 2016;113:DSU3

[Careful medical history taking is worthwhile in child sleep disorders].

Lindemalm S; Winbladh B
Article: ACTA PAEDIATRICA. 2015;104(9):956-961

In situ coating makes it easier for children to swallow and tolerate tablets and capsules.

El Edelbi R; Eksborg S; Lindemalm S
Article: BMC HEALTH SERVICES RESEARCH. 2014;14:655

Validation of triggers and development of a pediatric trigger tool to identify adverse events.

Unbeck M; Lindemalm S; Nydert P; Ygge B-M; Nylén U; Berglund C; Härenstam KP
Article: ACTA PAEDIATRICA. 2012;101(7):772-778

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study.

Kimland E; Nydert P; Odlind V; Böttiger Y; Lindemalm S
Article: ACTA PAEDIATRICA. 2012;101(5):540-544

Estimation of body surface area in various childhood ages--validation of the Mosteller formula.

El Edelbi R; Lindemalm S; Eksborg S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2011;67(10):1085-1089

Recent drug history in children visiting a pediatric emergency room and documentation in medical records.

Kimland E; Böttiger Y; Lindemalm S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2011;67(7):715-722

Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.

Nylén H; Sergel S; Forsberg L; Lindemalm S; Bertilsson L; Wide K; Diczfalusy U
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2011;170(5):583-588

Over-the-counter drug use--estimations within the Swedish paediatric population.

Nydert P; Kimland E; Kull I; Lindemalm S
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2011;20(4):393-398

Off-label drug use evaluation in paediatrics--applied to ciprofloxacin when used as treatment of cholangitis.

Nydert P; Lindemalm S; Nemeth A
Article: JOURNAL OF HUMAN LACTATION. 2009;25(2):199-205

Transfer of buprenorphine into breast milk and calculation of infant drug dose.

Lindemalm S; Nydert P; Svensson J-O; Stahle L; Sarman I
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2007;166(6):527-532

Drug related problems and off-label drug treatment in children as seen at a drug information centre.

Kimland E; Bergman U; Lindemalm S; Böttiger Y
Article: BMC PHARMACOLOGY. 2005;5:4

Application of population pharmacokinetics to cladribine.

Lindemalm S; Savic RM; Karlsson MO; Juliusson G; Liliemark J; Albertioni F
Article: CANCER LETTERS. 2004;210(2):171-177

Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.

Lindemalm S; Liliemark J; Juliusson G; Larsson R; Albertioni F
Article: HAEMATOLOGICA. 2003;88(3):324-332

Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.

Lindemalm S; Liliemark J; Gruber A; Eriksson S; Karlsson MO; Wang Y; Albertioni F
Article: LEUKEMIA RESEARCH. 2001;25(2):133-140

In vitro topo II--DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia.

Wang Y; Zhou R; Liliemark J; Gruber A; Lindemalm S; Albertioni F; Liliemark E
Article: MEDICAL ONCOLOGY. 1999;16(4):239-244

Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study.

Lindemalm S; Liliemark J; Larsson BS; Albertioni F
Article: CLINICAL CANCER RESEARCH. 1998;4(3):653-658

Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.

Albertioni F; Lindemalm S; Reichelova V; Pettersson B; Eriksson S; Juliusson G; Liliemark J
Article: ANTI-CANCER DRUGS. 1997;8(5):445-453

Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.

Lindemalm S; Albertioni F; Liliemark J
Show more

All other publications

Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1998;431:693-697

Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL).

Albertioni F; Lindemalm S; Eriksson S; Juliusson G; Liliemark J

Employments

Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2022-2025

Degrees and Education

Docent, Karolinska Institutet, 2016
Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2001
University Medical Degree, Karolinska Institutet, 1993

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI